Zobrazit v EDS

ارائه چارچوبی برای ارزیابی مدیریت تداوم کسب و کار با در نظر گرفتن عوامل کلیدی تأثیرگذار بر ارزش تداوم کسب و کار و ریسک ها در صنعت داروسازی.

Uloženo v:
Podrobná bibliografie
Název: ارائه چارچوبی برای ارزیابی مدیریت تداوم کسب و کار با در نظر گرفتن عوامل کلیدی تأثیرگذار بر ارزش تداوم کسب و کار و ریسک ها در صنعت داروسازی.
Alternate Title: Providing a Framework for Assessing Business Continuity Management, Considering Key Factors Affecting Business Continuity Value and Risks in the Pharmaceutical Industry.
Autoři: بختیار استادی1 bostadi@modares.ac.ir, حانیه رمضانیان ث2
Zdroj: Emergency Management (2345-3915). 2025, Vol. 14 Issue 2, p35-73. 39p.
Témata: *BUSINESS continuity planning, *RANK correlation (Statistics), *INDUSTRIAL management, *DELPHI method, *RESOURCE management
Abstrakt: In today's world, with the increase in the occurrence of disruptions and risks in organizations, preventing their recurrence or dealing with them has become increasingly important. With the concept of business continuity management, which is an inseparable part of risk management, a solution can be identified and implemented to recover critical processes or prevent long stops and interruptions for organizations. This research aims to identify factors affecting the business continuity value in the pharmaceutical industry, examine the relationships between business continuity management factors and business continuity value, and provide operational solutions based on the BCM assessment framework, focusing on the most important pharmaceutical risks. Business continuity management factors and risks in the pharmaceutical industry were identified using Grounded Theory and Delphi methods. Experts were selected from 5 pharmaceutical companies using the snowball technique to distribute and complete the Delphi questionnaires. The identified factors were confirmed in two Delphi rounds, and the Kendall coefficient was used to reach a consensus among experts. The collected data were analyzed descriptively and inferentially, and the Friedman test was used to examine the ranking of business continuity management factors, and the Spearman test was used to examine the research hypotheses. The BCM assessment framework was also implemented in 5 companies, and its data was examined for all companies. The findings of the Spearman test showed that there is a positive relationship between business continuity management factors and BCV, and an inverse relationship between pharmaceutical risks and BCV. The findings of implementing the business continuity management framework in pharmaceutical companies showed that controlling and reviewing programs and procedures, business continuity planning, business continuity culture, risk management, and resource management are the most important factors in the success of BCM, and the most important pharmaceutical risks are supply chain risk, product quality risk, microbiology risks, and research and development risks. The implementation of the framework in pharmaceutical companies showed that companies with higher BCV values have greater ability to cope with risk and process continuity, and will suffer fewer losses. [ABSTRACT FROM AUTHOR]
Databáze: Academic Search Index
Popis
Abstrakt:In today's world, with the increase in the occurrence of disruptions and risks in organizations, preventing their recurrence or dealing with them has become increasingly important. With the concept of business continuity management, which is an inseparable part of risk management, a solution can be identified and implemented to recover critical processes or prevent long stops and interruptions for organizations. This research aims to identify factors affecting the business continuity value in the pharmaceutical industry, examine the relationships between business continuity management factors and business continuity value, and provide operational solutions based on the BCM assessment framework, focusing on the most important pharmaceutical risks. Business continuity management factors and risks in the pharmaceutical industry were identified using Grounded Theory and Delphi methods. Experts were selected from 5 pharmaceutical companies using the snowball technique to distribute and complete the Delphi questionnaires. The identified factors were confirmed in two Delphi rounds, and the Kendall coefficient was used to reach a consensus among experts. The collected data were analyzed descriptively and inferentially, and the Friedman test was used to examine the ranking of business continuity management factors, and the Spearman test was used to examine the research hypotheses. The BCM assessment framework was also implemented in 5 companies, and its data was examined for all companies. The findings of the Spearman test showed that there is a positive relationship between business continuity management factors and BCV, and an inverse relationship between pharmaceutical risks and BCV. The findings of implementing the business continuity management framework in pharmaceutical companies showed that controlling and reviewing programs and procedures, business continuity planning, business continuity culture, risk management, and resource management are the most important factors in the success of BCM, and the most important pharmaceutical risks are supply chain risk, product quality risk, microbiology risks, and research and development risks. The implementation of the framework in pharmaceutical companies showed that companies with higher BCV values have greater ability to cope with risk and process continuity, and will suffer fewer losses. [ABSTRACT FROM AUTHOR]
ISSN:23453915